Gay, bisexual and other men who have sex with men in New
York City rate daily pre-exposure prophylaxis (PrEP) as the most effective HIV
prevention strategy when condoms aren’t used, and considerably more effective than
treatment as prevention or event-based PrEP, according to survey results published
in AIDS and Behavior. Men rated these
biomedical approaches far ahead of ‘strategic positioning’ or withdrawal before
ejaculation.
The online survey was run between November 2016 and June 2017.
While the city’s health department endorsed the “undetectable equals untransmittable”
campaign in August 2016, widespread public discussion of U=U came later. In
contrast, PrEP education and provision was already well established in New York
at the time of the survey, no doubt influencing the results.
But while all HIV-positive participants were aware of
treatment as prevention, few believed that it offered “complete protection”.
The 732 participants were all men who have sex with men,
living in New York City, recruited through advertisements on Facebook,
gay websites and dating apps. As part of a broader survey on sexual health for
men who have sex with men, they were asked:
“If an HIV-negative man and an HIV-positive man have anal
sex together without condoms, how
much protection would the following strategies provide against HIV
transmission?” Five strategies were presented.
- Daily PrEP: 70% believed this provided “a lot of” or “complete”
protection. Current or former PrEP users were more likely to perceive this efficacy
(86%) than other HIV-negative men (64%) or HIV-positive men (68%).
- Treatment as prevention (defined as, “the HIV-positive man maintains an
undetectable viral load”): 39% believed it offered “a lot of” or “complete”
protection. Ratings were higher among HIV-positive men (58%) and PrEP users
(49%) than other HIV-negative men (28%).
- Intermittent PrEP (“the HIV-negative man takes PrEP/Truvada only soon before or after sex –
like a day or two before and a day or two after”): 17% believed it offered protection.
- Strategic positioning (“the HIV-negative man limits himself to
the top position and the positive man to the bottom position”): 16% said this
would give “a lot of” or “complete” protection.
- Withdrawal (“if the HIV-positive man is the top, he makes
sure to pull out before ejaculation”): 11% said this provided protection.
Whereas scientific studies now clearly show there is effectively
no risk of HIV transmission from a sexual partner with a sustained undetectable
viral load (a position publicly endorsed by the CDC and New York’s public
health authorities), survey respondents showed some scepticism. Treatment as
prevention was rated as providing “complete” (rather than “a lot of”
protection) by 21% of HIV-positive respondents, 17% of PrEP users and 10% of other
HIV-negative men. Similarly, only a minority of men believed daily PrEP offered
complete protection.
Ratings for treatment as prevention did not vary by age,
ethnicity, education, relationship status or number of sex partners, but men
who identified as gay were more likely to believe it to be effective.
One in ten respondents (9.7%) did not know what PrEP was.
Similarly, 6.1% did not know the meaning of an undetectable viral load. Whereas
age, ethnicity and relationship status were not associated with lack of knowledge,
it was more common in men without a college education (15.1% unaware of PrEP
and 9.6% unaware of undetectable viral load) and men who identified as
bisexual, heterosexual or other (26.0% and 11.6% respectively).
Not knowing these terms was rare in people living with HIV
(2.3% and 0% respectively), but more common in HIV-negative men (11.3% and 7.5%
respectively).
“Much still needs to be done to promote TasP [treatment as prevention] and make the
strategy acceptable among MSM [men who have sex with men] and the general population,” the authors say. “Our
findings confirm that TasP promotion needs to reach out to people who are not
already engaged in HIV or PrEP care, and to MSM who do not identify as gay.”
Broadly similar findings were recently reported from an Australian study.